The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
The drug is currently being evaluated in two fully recruited global Phase 3 studies for progressive and tophaceous gout, with results expected in 2026.
The study also showed a clear dose-dependent trend, with the 75 mg QD group outperforming the 50 mg QD cohort
Clinical trial enrollment has long been a bottleneck in drug development
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
Her journey includes leading HR for large and diverse teams across sales, marketing, corporate functions, and R&D
All pending litigation between Biocon Biologics, Regeneron, and Bayer will be dismissed
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
Subscribe To Our Newsletter & Stay Updated
